Composition for preventing or treating cancer having resistance to anticancer agents
WO2026135396A1PCT designated stage Publication Date: 2026-06-25NEW CANCER CURE BIO CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- NEW CANCER CURE BIO CO LTD
- Filing Date
- 2025-12-22
- Publication Date
- 2026-06-25
Smart Images
Figure KR2025022506_25062026_PF_FP_ABST
Abstract
The present invention relates to a composition for preventing or treating cancer having resistance to anticancer agents and, more specifically, to a pharmaceutical composition for preventing or treating resistant cancer, comprising a 3-ketoacyl CoA thiolase (ACAA) inhibitor and a carnitine acylcarnitine carrier (CAC) inhibitor and inhibiting the regrowth of cancer having resistance to anticancer agents. It is has been identified that the composition comprising the 3-ketoacyl CoA thiolase (ACAA) inhibitor and the carnitine acylcarnitine carrier (CAC) inhibitor, of the present invention, effectively inhibits the regrowth of cancer cells and tumors having resistance to various anticancer agents, and thus can be effectively used for the prevention or treatment of cancer having resistance to anticancer agents.
Need to check novelty before this filing date? Find Prior Art